Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin
- PMID: 19948844
- PMCID: PMC2809826
- DOI: 10.1161/ATVBAHA.109.196576
Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin
Abstract
Objective: Vascular calcification is highly correlated with morbidity and mortality, and it is often associated with inflammation. Vitamin D may regulate vascular calcification and has been associated with cardiovascular survival benefits.
Methods and results: We developed a macrophage/smooth muscle cell (SMC) coculture system and examined the effects of vitamin D receptor activators (VDRA), calcitriol and paricalcitol, on SMC matrix calcification. We found that treatment of SMC alone with VDRA had little effect on phosphate-induced SMC calcification in vitro. However, coculture with macrophages promoted SMC calcification, and this was strikingly inhibited by VDRA treatment. Several VDRA-induced genes, including bone morphogenetic protein-2 (BMP2), tumor necrosis factor-alpha, and osteopontin, were identified as candidate paracrine factors for the protective effect of VDRA. Of these, osteopontin was further investigated and found to contribute significantly to the inhibitory actions of VDRA on calcification in macrophage/SMC cocultures.
Conclusions: The ability of VDRA to direct a switch in the paracrine phenotype of macrophages from procalcific to anticalcific may contribute to their observed cardiovascular survival benefits.
Figures





Similar articles
-
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.Kidney Int. 2012 Dec;82(12):1261-70. doi: 10.1038/ki.2012.322. Epub 2012 Aug 29. Kidney Int. 2012. PMID: 22932118 Free PMC article.
-
Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.Calcif Tissue Int. 2006 Dec;79(6):431-42. doi: 10.1007/s00223-006-0126-z. Epub 2006 Dec 8. Calcif Tissue Int. 2006. PMID: 17171500
-
Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol.J Cell Biochem. 2010 Nov 1;111(4):911-21. doi: 10.1002/jcb.22779. J Cell Biochem. 2010. PMID: 20665672 Free PMC article.
-
Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.Expert Opin Pharmacother. 2008 Apr;9(6):947-54. doi: 10.1517/14656566.9.6.947. Expert Opin Pharmacother. 2008. PMID: 18377338 Review.
-
Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.Drugs. 2007;67(14):1999-2012. doi: 10.2165/00003495-200767140-00003. Drugs. 2007. PMID: 17883284 Review.
Cited by
-
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.Kidney Int. 2012 Dec;82(12):1261-70. doi: 10.1038/ki.2012.322. Epub 2012 Aug 29. Kidney Int. 2012. PMID: 22932118 Free PMC article.
-
Vascular Calcification: Key Roles of Phosphate and Pyrophosphate.Int J Mol Sci. 2021 Dec 17;22(24):13536. doi: 10.3390/ijms222413536. Int J Mol Sci. 2021. PMID: 34948333 Free PMC article. Review.
-
Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study.Am J Hypertens. 2014 Nov;27(11):1346-54. doi: 10.1093/ajh/hpu057. Epub 2014 Apr 2. Am J Hypertens. 2014. PMID: 24695980 Free PMC article.
-
RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α.J Vasc Res. 2012;49(6):510-21. doi: 10.1159/000341216. Epub 2012 Aug 30. J Vasc Res. 2012. PMID: 22948607 Free PMC article.
-
Key parameters for designing robust 2D and 3D spheroid models for in vitro atherosclerosis research.Bioeng Transl Med. 2025 Mar 21;10(3):e10736. doi: 10.1002/btm2.10736. eCollection 2025 May. Bioeng Transl Med. 2025. PMID: 40385548 Free PMC article. Review.
References
-
- Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995;92:2157–2162. - PubMed
-
- Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998;31:126–133. - PubMed
-
- Loecker TH, Schwartz RS, Cotta CW, Hickman JR., Jr Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol. 1992;19:1167–1172. - PubMed
-
- Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol. 1964;92:865–871. - PubMed
-
- Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K, Naruko T, Haze K, Becker AE, Yoshikawa J, Ueda M. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110:3424–3429. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous